TY - JOUR
T1 - Distinct mortality patterns and sudden cardiac death mechanisms in heart failure with a preserved ejection fraction
AU - Sobue, Yoshihiro
AU - Watanabe, Eiichi
AU - Yanase, Masanobu
AU - Izawa, Hideo
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/12
Y1 - 2025/12
N2 - Sudden cardiac death (SCD) is a leading cause of mortality in heart failure (HF), yet its incidence, mechanisms, and predictors in heart failure with preserved ejection fraction (HFpEF) remain poorly characterized. We conducted a prospective study of 2331 patients hospitalized for decompensated HF, stratifying them into HFpEF (n = 754), HF with mid-range ejection fraction (HFmrEF, n = 369), and HF with reduced ejection fraction (HFrEF, n = 1208). Over a median 25-month follow-up, 298 patients (12.8%) experienced SCD. HFpEF patients had the lowest SCD incidence (5.9%) compared to HFmrEF (13.8%) and HFrEF (16.7%) (p < 0.01). Asystole predominated in HFpEF SCD cases (52.9%), whereas ventricular tachyarrhythmias dominated in HFmrEF and HFrEF. In multivariate competing risk analysis, NYHA class III (cause-specific hazard ratio [csHR] 2.04, 95% CI 1.20–3.45, p < 0.01; subdistribution hazard ratio [sHR] 1.56, 95% CI 1.16–1.96, p = 0.01) and prolonged QTc interval > 480 ms (csHR 1.63, 95% CI 1.03–2.55, p = 0.01; sHR 1.57, 95% CI 1.04–2.38, p = 0.03) independently predicted SCD in patients with HFpEF. These findings reveal distinct SCD patterns in HFpEF and underscore the need for phenotype-specific risk stratification and prevention strategies.
AB - Sudden cardiac death (SCD) is a leading cause of mortality in heart failure (HF), yet its incidence, mechanisms, and predictors in heart failure with preserved ejection fraction (HFpEF) remain poorly characterized. We conducted a prospective study of 2331 patients hospitalized for decompensated HF, stratifying them into HFpEF (n = 754), HF with mid-range ejection fraction (HFmrEF, n = 369), and HF with reduced ejection fraction (HFrEF, n = 1208). Over a median 25-month follow-up, 298 patients (12.8%) experienced SCD. HFpEF patients had the lowest SCD incidence (5.9%) compared to HFmrEF (13.8%) and HFrEF (16.7%) (p < 0.01). Asystole predominated in HFpEF SCD cases (52.9%), whereas ventricular tachyarrhythmias dominated in HFmrEF and HFrEF. In multivariate competing risk analysis, NYHA class III (cause-specific hazard ratio [csHR] 2.04, 95% CI 1.20–3.45, p < 0.01; subdistribution hazard ratio [sHR] 1.56, 95% CI 1.16–1.96, p = 0.01) and prolonged QTc interval > 480 ms (csHR 1.63, 95% CI 1.03–2.55, p = 0.01; sHR 1.57, 95% CI 1.04–2.38, p = 0.03) independently predicted SCD in patients with HFpEF. These findings reveal distinct SCD patterns in HFpEF and underscore the need for phenotype-specific risk stratification and prevention strategies.
KW - HFpEF
KW - QTc
KW - Risk stratification
KW - Sudden cardiac death
KW - Ventricular arrhythmias
UR - https://www.scopus.com/pages/publications/105019531110
UR - https://www.scopus.com/pages/publications/105019531110#tab=citedBy
U2 - 10.1038/s41598-025-20924-8
DO - 10.1038/s41598-025-20924-8
M3 - Article
C2 - 41131009
AN - SCOPUS:105019531110
SN - 2045-2322
VL - 15
JO - Scientific reports
JF - Scientific reports
IS - 1
M1 - 37048
ER -